IRONWOOD PHARMACEUTICALS INC 8-K

What Happened

• On May 7, 2026 Ironwood Pharmaceuticals, Inc. (IRWD) issued a press release providing an update on recent business activities and reporting results for the quarter ended March 31, 2026.
• The press release was furnished as Exhibit 99.1 to a Current Report on Form 8-K filed under Item 2.02 (Results of Operations and Financial Condition).

Key Details

• Press release date: May 7, 2026 (Exhibit 99.1).
• Reporting period covered: Quarter ended March 31, 2026 (Q1 2026).
• Form 8-K items reported: 2.02 (Results of Operations and Financial Condition) and exhibit information under 9.01.

Why It Matters

• The filing signals the company has publicly released its latest quarterly results and business update — information investors use to assess revenue, earnings, product or regulatory developments, and near-term outlook.
• Investors should read the May 7 press release (Exhibit 99.1) and any accompanying SEC filings for specifics on revenue, earnings, guidance, and operational highlights that could affect the stock.